Nanor Sirab

2.4k citations
14 papers · 628 indexed · h-index 10
Topics
Bladder and Urothelial Cancer Treatments (4 papers)Molecular Biology Techniques and Applications (4 papers)Epigenetics and DNA Methylation (4 papers)
Partner nations
FranceUnited States

In The Last Decade

Nanor Sirab

14 papers receiving 620 citations

Peers

Nanor Sirab
Comparison fields: 5 of 75
  • Molecular Biology 274
  • Pulmonary and Respiratory Medicine 257
  • Urology 179
  • Oncology 94
  • Cancer Research 90
Replace Vera Ray with:
Vera Ray United States
Pilar Martínez-Onsurbe Spain
Tomoyuki Koguchi Japan
Shingo Kuroda Japan
Xiangguang Shi China
Sana Jadallah United States
Jinxian Pu China
Romana Illig Austria
Nayara Izabel Viana Brazil
Tian Yang China
Nanor Sirab relative to Vera Ray United States Vera Ray's profile →
Citations per field
00.5×6.7×
Vera Ray · 1×
Citations per year

Countries citing papers authored by Nanor Sirab

Since Specialization
Citations

This map shows the geographic impact of Nanor Sirab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nanor Sirab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nanor Sirab more than expected).

Fields of papers citing papers by Nanor Sirab

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nanor Sirab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nanor Sirab. The network helps show where Nanor Sirab may publish in the future.

Co-authorship network of co-authors of Nanor Sirab

This figure shows the co-authorship network connecting the top 25 collaborators of Nanor Sirab. A scholar is included among the top collaborators of Nanor Sirab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nanor Sirab. Nanor Sirab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 2
2 12
3 18
4 26
5 20
6 32
7 22
8 1
9 121
10 77
11 3
12 227
13 7
14 60

About Nanor Sirab

Nanor Sirab is a scholar working on Pulmonary and Respiratory Medicine, Biophysics and Biochemistry, having authored 14 papers that have together received 628 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (4 papers), Molecular Biology Techniques and Applications (4 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Urology (179 citations), Pulmonary and Respiratory Medicine (257 citations) and Cancer Research (90 citations). Nanor Sirab has collaborated with scholars based in France and United States. Frequent co-authors include Alexandre de la Taille, Francis Vacherot, Stéphane Terry, Yves Allory, Pascale Maillé, Nathalie Nicolaı̈ew, G. Robert, A. Descazeaud, Sylvain Loric and Pascale Soyeux. Their work appears in journals such as Cancer Research, International Journal of Molecular Sciences and The Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026